PharmStars

Neuroventis is a digital platform focused on neurology, designed to assist patients in managing their neurological disorders. The platform operates as a CE-marked medical device, allowing users to register their health conditions and share relevant data with their medical teams. By enhancing the interaction between patients and healthcare professionals, Neuroventis aims to empower patients to take an active role in their health management. This approach fosters stronger partnerships in clinical practice and supports patients in overcoming the challenges associated with their conditions.

HealthQb is a company that focuses on remotely monitoring the biopsychosocial health of patients, particularly those with chronic illnesses. It provides a behavior modification system that utilizes wearables or smartwatches, accompanied by a patient application and healthcare portal. This technology enables healthcare providers, including physiotherapists and other practitioners, to access objective assessments of their patients' health. By doing so, they can guide patients towards achieving their health goals and addressing the root causes of unhealthy behaviors. HealthQb's approach aims to empower both patients and healthcare professionals in the management and improvement of health outcomes.

WKD.SMRT provides a platform that combines remote interaction with state-of-the-art digital technologies to deliver accurate and complete real-world data. They integrates data in the home with third party data and conventional clinical examinations.

Developer of an AI-powered neurodiagnostic software intended for clinicians to treat dementia patients. The company's platform analyzes EEG data to identify brainwave patterns that are associated with the onset or progression of Alzheimer's and dementia conditions, enabling clinicians to conduct earlier and more efficient clinical trials, while accelerating the development of effective treatments.

Head Diagnostics is a life sciences technology company that specializes in the development of a non-invasive medical device designed to assess and evaluate brain impairment and disease. This innovative device allows for rapid assessment of concussions without the need for an initial baseline test, providing objective evaluations. By delivering real-time neuro data to hospitals, neurologists, physicians, and patients, Head Diagnostics aims to enhance patient outcomes and reduce reliance on traditional imaging methods such as CT scans.

Nori Health operates a healthcare platform designed to provide personalized support for individuals living with chronic diseases, particularly those with inflammatory bowel disease. The platform features a chatbot that engages users in regular conversations, helping them identify and modify lifestyle factors that may exacerbate their condition. By facilitating these lifestyle changes, Nori Health aims to improve patients' overall quality of life and alleviate symptoms such as fatigue, pain, and anxiety. The service focuses on empowering users to take control of their health through tailored guidance and support.

Liyfe is a telemedicine platform focused on cancer care, offering services such as personalized triage pathways for oncology patients. Utilizing an AI-based digital nurse chatbot, Liyfe automates symptom management and enhances the detection of high-risk patients. The platform provides a membership program that allows patients unlimited access to nurse practitioners via text and video chat for a monthly fee comparable to a co-pay. This service ensures 24/7 virtual care, facilitating timely medical support. Additionally, Liyfe's user-friendly electronic medical record (EMR) system allows patients to store and access their medical history securely. The platform is designed to educate patients on home symptom management while addressing their nutritional and emotional needs, thereby improving overall patient care and experience.

EVOCAL Health is a digital diagnostics company focused on utilizing vocal biomarkers and artificial intelligence to enhance disease detection and health monitoring. By developing advanced healthcare intelligence algorithms, the company analyzes voice, breathing, and coughing sounds to identify potential health issues. This innovative approach aims to transform disease detection through its accuracy, speed, and cost-effectiveness, making it accessible to a broader population. By leveraging everyday technology such as smartphones, EVOCAL Health seeks to democratize healthcare, enabling users to detect and diagnose diseases on a global scale and from virtually anywhere.

SmartTab is a pharmaceutical company that focuses on developing the Smart Drug Delivery and Monitoring Systems. Its platform technology is a wireless ingestible capsule containing an electronic receiver, smart polymer actuator, and active ingredients. The company is focused on the development of three drug delivery platforms, TargetTab™, InjectTab™ and MultiTab™. The company was founded in 2015 and headquartered in Denver, Colorado, United States.

The Clinician Ltd is a health technology company specializing in the development of ZeDoc, a cloud-based platform that facilitates the collection and analysis of patient-reported outcome measures (PROMs). Founded in 2015 and headquartered in Auckland, New Zealand, with an additional office in Singapore, the company aims to enhance patient engagement and care outcomes while improving organizational efficiency and reducing costs. ZeDoc integrates seamlessly into existing clinical workflows, utilizing artificial intelligence-driven chatbots and data science techniques to minimize the burden of patient questioning. The platform allows healthcare providers to monitor real-time data from various health tracking devices and wearables, supporting the assessment of multiple patient cohorts and the identification of at-risk cases. By enabling effective communication between patients and care teams, The Clinician promotes a patient-centric, value-based care approach throughout the patient care continuum.

Droice Labs is an AI company specializing in understanding real-world clinical data to solve problems across the healthcare system. Our solutions provide answers to the key questions that healthcare entities have, helping them to make optimal decisions and to better understand diseases and the patients they affect. Our products use state of the art AI to help identify undiagnosed/misdiagnosed/mistreated patient populations. The insights are valuable for all stakeholders in healthcare: hospitals gain revenue in risk-sharing contracts, payers save money through increasing care efficiency, and life sciences identifies populations where their therapies perform appropriately. We use this technology to help payers, providers and hospital finance teams to fill documentation correctly, capture missed revenue, and fill care gaps. With our deep patient and disease understanding engine, we also help payers detect over-billing, design better plans and prioritize the right interventions to cover.

nQ Medical Inc., founded in 2016 and based in Cambridge, Massachusetts, specializes in developing innovative solutions for the detection and management of neurocognitive and neuromotor disorders. The company has created neuroQWERTY, an artificial intelligence tool that passively collects data through everyday use of electronic devices, enabling 24/7 monitoring of disease progression and therapeutic effectiveness. This frictionless and non-invasive platform captures subtle changes in user interactions, such as typing and touchscreen behavior, which are often overlooked by traditional clinical assessments. With proven capabilities demonstrated in extensive clinical trials, nQ Medical aims to facilitate early detection of disorders like Alzheimer's, Parkinson's, and multiple sclerosis, while offering a cost-effective alternative to current diagnostic methods. By providing patients and clinicians with a reliable means to track disease status and treatment impact, nQ Medical is positioned to enhance the management of neurological conditions significantly.

EVOCAL Health is a digital diagnostics company focused on utilizing vocal biomarkers and artificial intelligence to enhance disease detection and health monitoring. By developing advanced healthcare intelligence algorithms, the company analyzes voice, breathing, and coughing sounds to identify potential health issues. This innovative approach aims to transform disease detection through its accuracy, speed, and cost-effectiveness, making it accessible to a broader population. By leveraging everyday technology such as smartphones, EVOCAL Health seeks to democratize healthcare, enabling users to detect and diagnose diseases on a global scale and from virtually anywhere.